UPDATED Mar 18, 2024
Companies below a US$500M market cap with strong earnings growth forecasted for the next 3 years.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NVG | zł2.39 | -4.4% | 81.1% | zł83.7m | zł3.71 | PE8.6x | E28.5% | n/a | Diversified Financials | ||
ELABS | kr14.66 | 0.1% | -4.2% | kr1.5b | kr25.00 | PS22.5x | E124.6% | n/a | Software | ||
MVW | kr9.10 | 1.1% | 10.7% | kr265.7m | kr12.20 | PS24.1x | E66.0% | n/a | Materials | ||
KEBNI B | kr1.40 | -3.2% | 4.2% | kr378.5m | kr1.80 | PS5.3x | E137.8% | n/a | Tech | ||
NOHAL | kr22.80 | 2.7% | -13.0% | kr891.6m | kr32.50 | PS8.7x | E56.0% | n/a | Food, Beverage & Tobacco | ||
FDE | €35.75 | -11.5% | -5.5% | €187.0m | €68.07 | PE15.6x | E25.8% | n/a | Energy | ||
ATAKP | ₺50.10 | -9.4% | n/a | ₺7.0b | ₺67.66 | PE14.7x | E67.3% | n/a | Food, Beverage & Tobacco | ||
AGP | €7.40 | -9.8% | 172.6% | €128.1m | €12.05 | n/a | E26.0% | n/a | Capital Goods | ||
OSE | €4.86 | -5.6% | -5.6% | €104.8m | €7.15 | PS29x | E81.1% | n/a | Pharmaceuticals & Biotech | ||
RDUE | €8.34 | 0.7% | -28.1% | €52.1m | €11.70 | n/a | E42.0% | n/a | Capital Goods | ||
GIG | kr32.05 | -3.3% | 28.7% | kr4.1b | kr49.20 | PE26.7x | E39.2% | n/a | Consumer Services | ||
MBTN | CHF0.035 | -41.7% | -93.1% | CHF125.5m | n/a | PB0.7x | E100.6% | n/a | Semiconductors | ||
SO | лв21.00 | 2.9% | n/a | лв216.5m | лв21.25 | PE19.5x | E23.9% | 0% | Food, Beverage & Tobacco | ||
RCEL | US$15.83 | -3.7% | 19.8% | US$407.9m | US$26.49 | PS8.1x | E64.0% | n/a | Pharmaceuticals & Biotech | ||
GWIND | ₺25.30 | -4.8% | 53.4% | ₺13.5b | ₺39.79 | PE12.9x | E45.3% | 1.8% | Utilities | ||
ZVRA | US$5.96 | -2.8% | 20.4% | US$247.3m | US$18.25 | PS14.9x | E59.5% | n/a | Pharmaceuticals & Biotech | ||
GTHX | US$3.21 | -7.8% | 9.2% | US$167.6m | US$8.50 | PS2x | E55.1% | n/a | Pharmaceuticals & Biotech | ||
PRL | CA$16.12 | -4.6% | 128.3% | CA$553.4m | CA$23.20 | PE14.7x | E33.6% | 3.0% | Diversified Financials | ||
HHR | AU$0.007 | 0% | -81.6% | AU$18.3m | n/a | PE6.7x | E86.3% | n/a | Energy | ||
CYC | AU$1.78 | 1.1% | 23.6% | AU$169.4m | AU$4.62 | PS6.2x | E92.8% | 0% | Healthcare | ||
3DA | AU$0.34 | -8.0% | 165.4% | AU$177.5m | n/a | PS197.2x | E85.2% | n/a | Capital Goods | ||
CAI | AU$0.17 | 10.0% | -29.8% | AU$101.1m | n/a | PB0.7x | E110.6% | n/a | Materials | ||
A204620 | ₩4,860.00 | -1.4% | 57.8% | ₩276.0b | ₩7,000.00 | PE95.3x | E101.0% | n/a | Commercial Services | ||
A211050 | ₩22,250.00 | -4.3% | 100.1% | ₩219.4b | ₩19,000.00 | PE8.8x | E48.1% | 1.3% | Insurance |